Clinical Trial Update: Pharmacodynamics and Safety of CDFR0209 [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting pharmacodynamics and safety data for CDFR0209 in gastric ulcer and gastroesophageal reflux disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• CDFR0209

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Stomach Ulcer, Gastroesophageal Reflux | Phase 1 | Status: COMPLETED